| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $316.9M | $283.2M | $144.5M |
| YoY Revenue Growth % | +11.9% | +96.0% | — |
| Gross Profit | $9.5M | $8.3M | — |
| Gross Margin % | 3.0% | 2.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$4.3M | -$834.1K | -$315.5K |
| Operating Margin % | -1.3% | -0.3% | -0.2% |
| Net Income (GAAP) | -$8.5M | -$5.2M | -$763.3K |
| EBITDA (Normalized) | -$4.2M | -$712.8K | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$3.8M | -$2.9M | -$1.5M |
| Capital Expenditures (CapEx) | $113.0K | $151.6K | — |
| Free Cash Flow (FCF) | -$4.0M | -$3.1M | -$1.5M |
| FCF Margin % | -1.2% | -1.1% | -1.0% |
| Return on Invested Capital (ROIC %) | -23.7% | -7.0% | — |
| Cash & Short-Term Equivalents | $2.2M | $2.5M | — |
| Total Debt (Short + Long Term) | $31.3K | — | — |
| Total Stockholders' Equity | $16.3M | $11.9M | — |